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Purpose: To determine the frequency of occurrence of Enterobacter species and their antibiogram from 
clinical specimens of blood, cerebrospinal fluid, urine and wound obtained from University of Benin 
Teaching Hospital, Benin City, Nigeria. 
Methods: Specimens were obtained from patients who were seen at the various units of the hospital 
during the period January 2008 to June 2010. The total number of specimens was 6632, and were 
obtained from 1678 adult males, 2010 adult females and 2944 children. The specimens were collected 
prior to commencement of antibiotic therapy, and cultured immediately using standard bacteriological 
methods. Growths were identified by colonial morphology and characteristics, and biochemical 
reactions. Antimicrobial sensitivity test was performed according to Kirby-Bauer disc diffusion method as 
per Clinical and Laboratory Standards Institute (CLSI) recommendation. The control organism was a 
sensitive strain of Eschrichia coli (NCTC 10418) 
Results: Two species of Enterobacter, namely, E. aerogenes (104; 97.2 %) and E. sakazakii (3; 2.8 %) 
were isolated from the four types of clinical specimens, accounting for 1.6 % of all the samples. 
Sensitivity to antibacterials was as follows: ceftazidime (55.0 %), ofloxacin (53.3 %) and amoxicillin 
clavulanate (48.3 %). They were strongly resistant to the other antibiotics used in the study, especially 
the cephalosporins. There was no significant difference in infection rate among the age groups (p > 
0.05). However, there was significant difference (p < 0.05) between isolates from cerebrospinal fluid, on 
the one hand, and those from wound, urine and blood, on the other hand.  
Conclusion: The rate of isolation of Enterobacter species in the health facility was low. Remarkable 
drug resistance of the organisms make them clinically significant pathogens.     
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INTRODUCTION 
 
Enterobacter aerogenes, E. Cloacae and E. 
sakazakii are commonly encountered 
Enterobacter spp. in most clinical specimens. 
These three species are differentiated by 
urease test and pigment production. E. 
cloacae is urease positive while the other two 
are negative. E. sakazakii produces yellow 
pigment which differentiates it from the other 
two species [1]. 
 
These organisms are Gram-negative 
capsulated bacilli and in the Petri dish, form 
round mucoid colonies; optimum growth 




 Enterobacter species 
are similar to Klebsiella species with large 
round mucoid colonies, but can be 
differentiated by a few tests such as motility 
and urease tests [2]. They are facultatively 
anaerobic, catalase positive, citrate positive, 
indole negative and oxidase negative. They 
ferment glucose and lactose with the 
production of acid, and are sucrose positive 
[2]. 
 
The organisms are distributed in water, soil, 
sewage, dairy products and vegetables, are 
part of the commensal enteric flora and 
usually are not pathogenic. However, some 
strains are known to produce shig-like toxin 
[3]. Enterobacter species have also been 
associated with nosocomial infections and a 
variety of opportunistic infections involving 
the urinary and respiratory tracts, and 
cutaneous wounds. E. sakazakii which is a 
pigmented strain of E. cloacae has been 
encountered in several cases of meningitis, 
bacteremia and sepsis [4]. It has also been 
associated with outbreak of necrotizing 
enterocolitis associated with the strain in 
powdered milk formula, and fatality rate is as 
high as 75 %. [5,6]. These enterobacter 
organisms cause significant morbidity and 
mortality. They can also cause community 
acquired infections resulting in endocarditis, 
intra-abdominal infections, septic arthritis, 
osteomyelitis and ophthalmic infections [7]. 
Risk factors for nosocomial infections include 
hospitalization for more than 2 weeks, 
invasive procedures and presence of central 
venous catheter, hands of hospital personnel 
and hospital equipments. Enterobacter 
species has an outer membrane that contains 
among other things lipopolysaccharides from 
which Lipid-A plays a major role in sepsis. 
Lipid-A, which is an endotoxin, is the major 
stimulus for the release of cytokines which 
are the mediators of systemic inflammation 
and its complications [8] Enterobacter 
species are resistant to most antibiotics, 
especially the cephalosporins. Their 
resistance to β-lactam antibiotics, chloram-
phenicol, quinolones and tetracyclines have 
been well documented [9]. Reports abound in 
the literature on the increasing resistance of 
Enterobacter species to the penicillins and all 
generations of cephalosporins, and their 
emergence in clinical specimens. 
 
The paucity of information on the clinical 
significance of the Enterobacter species in 
Edo State south-central Nigeria, necessitated 
this study, the aim of which was to determine 
the frequency of isolation of Enterobacter 
species and their antibiogram from clinical 
specimens obtained from University of Benin 
Teaching Hospital, Benin City, Edo State, 






Chocolate and blood agars, McConky agar, 
nutrient agar (oxoid no cm 2), Cistern lactose 
electrolyte deficient (CLED) agar, brain heart 
infusion broth and thioglycolate broth were all 




The study, which was prospective and cross-
sectional, was carried out at the University of 
Benin Teaching Hospital (UBTH), Benin City, 
Nigeria. The hospital has a bed complement 
of six hundred (600) and an equipped 
microbiology laboratory that provides 
laboratory services to the neighbouring states 
of Ondo, Delta, Kogi and Anambra. 
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Sampling method 
 
The samples used in the study were obtained 
consecutively from patients who were seen at 
the various facilities in the hospital during the 
period January 2008 to June 2010. The 
patient population was 6632, comprising 
1678 (25.30 %) adult males, 2010 (30.32 %) 
adult females and 2944 (44.38 %) children. 
Only one sample per patient was obtained. 
The clinical specimens consisted of wound, 
blood, cerebrospinal fluid and urine.  
 
The number of wound specimens was 2960 
(44.63 %) made up of 1040 (35.1 %) from 
adult males, 920 (31.1 %) from adult females 
and 1000 (33.8 %) from children. Urine 
samples numbered 1840 (27.74 %) 
comprising 610 (33.2 %) from adult males, 
960 (52.2 %) from adult females and 270 
(16.7 %) from children. Blood samples 
numbered 328 (4.95 %) made up of 18 (5.5 
%) from adult males, 109 (33.2 %) from adult 
females and 201 (61.3 %) from children. The 
total number of cerebrospinal fluid samples 
was 1504 (22.7 %) consisting of 10 (0.7 %) 
from adult males, 21(1.4 %) from adult 
females and 1473 (97.9 %) from children. 
 




Wound swab was cultured on blood and 
MacConkey agars. The specimens were 
aseptically inoculated on the media and 
streaked to obtain distinct colonies [10]. After 
inoculating on media, a grease-free slide was 
smeared for Gram staining and microscopy. 
Two blood agar plates inoculated with 
specimen were incubated - one aerobically 
and the other anaerobically. The anaerobic 
incubation was done using a gas pact in an 
anaerobic jar. The pact was cut on one side 
to introduce 10 ml of water and placed in a jar 
along with the plates for anaerobic 
incubation. The jar was closed and was not 




Blood samples were aseptically collected 
from patients, 1 ml of which was aseptically 
introduced into nutrient and thioglycollate 
broths in bottles and incubated at body 
temperature (37 
o
C). The bottles were 
examined daily for growth (which manifests 
as turbidity or gas bubbles). Where growth 
was detected, the nutrient broth was 
subcultured on chocolate, blood and 
MacConkey agars and incubated aerobically 
while thioglycollate broth was subcultured on 
blood agar and incubated anaerobically as 
described above. Following subculture, Gram 




Cerebrospinal fluid (0.5 ml) was obtained 
through a spinal tap and cultured immediately 
on chocolate, blood and MacConkey agar 
plates. Gram staining and microscopy were 
carried out. The culture on chocolate plate 
was incubated in 5 - 10% carbon dioxide 






Urine was obtained in a 20 ml sterilin 
container and after thorough mixing, a wire 
loop (30 morse gauge) with a chamber of 
3.26 mm circumference was used to streak 
the mixed urine on blood, MacConkey 
andCLED agars, and incubated aerobically 
for 24 h. All the plates were incubated at a 
temperature of 37
 o
C. Isolates were identified 
based on colonial morphology, motility, Gram 
staining, oxidase and biochemical reactions 




Susceptibility of isolates was determined by 
the agar diffusion method, using a 
modification of Kirby-Bauer disc diffusion 
technique [12]. The antibiotic discs (Abtek 
Biologicals Ltd, Liverpool, England) were: 
ceftazidime 30 µg, ofloxacin 5 µg, amoxicillin 
clavulanate 30 µg, gentamycin 10 µg, 
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ceftriazone 30 µg, cefuroxime 30 µg, 
cefotaxime 30 µg, cloxacillin 10 µg, 
furadantoin 300 µg, and erythromycin 10 µg.  
 
Isolates from overnight culture were used for 
the sensitivity test. A colony of the isolate 
was picked with a straight sterile wire, 
inoculated into sterile 5 ml peptone water, 
shaken to dissolve it and poured on a sterile 
nutrient agar plate. The inoculated agar plate 
was swayed gently to ensure that the whole 
agar surface was covered. The plate was 
drained to remove excess fluid. The antibiotic 
discs were placed on the agar surface, 
leaving a space of 25mm between them,  and 
pressed slightly to ensure sufficient contact 
with the agar surface. The plates were then 
incubated at 37
 o
C for 24 h. The inhibition 
zone diameter (IZD) was measured, and IZD 
< 5 mm was taken as resistance while IZD > 
5 mm was considered sensitive.  
 
Statistical analysis  
 
Gen Stat software (release 8.1) was used to 
analyze the data obtained. Differences in the 
distribution of isolates among the age groups 
as well as among the clinical specimen types 
were determined while statistically significant 
differences were computed Student’s t-test 
and analysis of variance (ANOVA). 
Differences between specimen types (p 
<0.05) was determined using Duncan 




The specimens (6632) yielded 107 (1.6%) 
isolates of enterobacter species.There were 
104 Enterobacter aerogenes and 3 
Enterobacter sakazakii spp. The distribution 
of organisms among the age groups are 
shown in Table 1. There was no significant 
difference in the distribution of isolates 
among the age groups (p < 0.05). However, 
as Table 2 shows, there was a significant 
difference between isolates from 
cerebrospinal fluid and those from other 
specimens (p < 0.05) except for the isolates 
from blood specimens.  
 
The susceptibility of the Enterobacter isolates 
to various antibiotics is shown in Tables 4 
and 5. 
 
Based on the antibiogram, Enterobacter 
aerogenes was moderately sensitive to 
ceftazidime, ofloxacin and amoxicillin 
clavulanate while showing strong resistance 
to the other drugs. Enterobacter sakazakii, on 
the other hand, exhibited higher susceptibility 
to the antibiotics except erythromycin, 
cloxacillin and oxacillin. Enterobacter 
aerogenes, which was isolated from urine, 
demonstrated good susceptibility to 
nitrofuradantoin but was moderately 




Table 1: Distribution of isolates from specimens among adult males, females and children 
 
Distribution of isolates Specimen 
Total     Adult male   Female adult  Children 
Frequency 
(%) 
Wound 45 8 12 25 0.71 
Urine 44 15 22 7 0.61 
Blood 17 2 3 12 0.25 
CSF* 1 Nil Nil 1 0.01 
Total 107 25 (0.37%) 37 (0.56%) 45 (0.68%) 1.58  
*Cerebrospinal fluid based on the total number of samples  
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Proteus rettgerri 383 5.77 
Staphylococcus aureus 1564 23.58 
Klebsiella pneumoniae 638 9.65 
Escherichia coli 782 11.79 
Pseudomonas aeruginosa 686 10.33 
Alcaligenes faecali 628 9.47 
Providencia stuartii 293 4.41 
Proteus mirabilis 498 5.51 
Proteus vulgaris 438 6.60 
Proteus morganii 194 2.93 
Candida albicans 283 4.27 
 
 
        Table 3: Distribution of Enterobacter spp among the specimens 
 
Distribution of isolates 
Specimen 
Total E. aerogenes E. sakazakii 
Frequency 
(%) 
Wound 45 45 Nil 0.71 
Urine 44 44 Nil 0.61 
Blood 17 14 3 0.25 
CSF* 1 1 Nil 0.01 
Total 107 104 3 1.58 
*Cerebrospinal fluid  
 
 
Table 4: Antibiogram of E. aeroges and E sakazakii in wound, blood and cerebrospinal fluid specimens  
(percentages in parentheses) 
 
Organism Caz Ofx Aug CN CXM CRO CTX E CL OXC OB 








































Caz = ceftazidime; Ofx = ofloxacin; Aug = amoxicillin clavulanate; CN = gentamicin; CXM = cefuroxime; 




Table 5: Antibiogram of E. aerogenes isolated from urine specimens (percentages in parentheses) 
 























Caz = ceftazidime; Ofx = ofloxacin; Aug = amoxicillin clavulanate; CN = gentamicin;  
CXM = cefuroxime; CRO = ceftriaxone; CTX = cefotazime; E = erythromycin; CL = cephalezime; OXC = oxacillin; OB = 
cloxacillin 
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DISCUSSION 
 
The study shows a very low distribution of 
Enterobacter species in University of Benin 
Teaching Hospital. The existence of many 
enterobacter species in clinical samples has 
been reported [7]. The present study found 
mainly E. aerogenes and an insignificant 
number of Enterobacter sakazakii. Other 
reports in the literature claimed the presence 
of E. cloacae, E. taylorae, E. aerogenes and 
E sakazakii in clinical specimens [13]. E 
aerogenes, which was the predominant 
isolate in our study, is commonly 
encountered in clinical specimens. It is known 
to be associated with a variety of 
opportunistic infections [3]. It is associated 
with infections involving the urinary and 
respiratrory tracts, and cutaneous wounds, 
and occasionally causes sepsis and 
meningitis. E. sakazakii which was scantily 
encountered in the study has been reported 
in several cases of neonatal meningitis and 
sepsis, and has a high fatality rate [4]. Thus, 
the organism can be highly virulent [5,6]. 
Recent reports have linked E. sakazakii 
infection in neonates with contaminated 
powdered milk formulas [14]. 
 
The epidemiology of Enterobacter infection 
as seen from this study appear to place 
children at relatively higher risk of infection, 
followed by adult females, with adult males 
least predisposed to infection. However, the 
differences were not statistically significant (p 
> 0.05).  This mean that all age groups and 
gender types are equally predisposed to 
infection. Children are, however have been 
known to be most susceptible to any infection 
as a result of habits, exposure and lower 
immunity. Enterobacter infection is largely 
associated with decreased immunity. Those 
heavily affected are the immunocompromised 
as well as factors such as increased length of 
stay in the hospital; increased length of stay 
in the intensive unit; those on urinary catheter 
and long term antibiotic administration [15]. 
The distribution of enterobacter species in the 
clinical specimens indicated a significant 
difference among the specimen types. There 
was statistically no difference in the 
distribution of isolates in the other specimen 
categories. Thus cerebrospinal fluid (CSF) is 
the least likely to be infected Enterbacter spp. 
This  may be due to the fact that organisms 
do not easily gain access to the cerebrospinal 
fluid as a result of some sort of barrier.  
 
The antibiogram showed that Enterobacter 
aerogenes exhibited high resistance to the 
antibiotics used in the study; these are also 
the antibiotics commonly used in these 
setting for the treatment of infections. The 
observed resistance is agrees with literature 
reports which claimed that Enterobacter 
species are reisistant to most antibiotics. The 
resistance of this species to β-lactam 
antibiotics, chloranphenicol, quinolones and 
tetracycline is well documented in scientific 
literature [9]. There are numerous reports in 
the literature on the increasing resistance of 
Enterobacter species to penicillins and all 
generations of cephalosporins and their 
emergence in clinical specimens [9]. 
 
The antibiogram of Enterobacter sakazakii 
showed the organism to be more susceptible 
to most antibiotics, except oxacillin and 
cloxacillin Enterobacter aerogenes was the 
only species of Enterobacter that was 
isolated from urine specimens and they 
exhibited a slightly different antibiogram. 
They were less susceptible than those from 
wound, blood and cerebrospinal fluid. 
However, the high susceptibility to 
furadantoin is an indication that the drug 
could be the drug of choice for any 
Enterobacter urinary tract infection. They 
were moderately susceptible to ceftaxidime 
and ofloxacin. The high resistance to other 





The Enterobacter species, like other 
members of Enterobacteriaceae family 
contain an outer membrane which contains, 
among others, lipopolysaccharides of which 
lipid-A plays a major role in sepsis. Lipid-A, 
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which is an endotoxin, is the major stimulus 
for the release of cytokines which are the 
mediators of systemic inflammation and its 
complications [8]. In the present study, 
ceftaxidime (a cephalosporin) and ofloxacin 
(a quinolone) exhibited some moderate 
efficacy and thus could be effective in the 
management of Enterobacter infection. This 
observation contradicts some literature 
claims which reported that Enterobacter spp 
are resistant to these drugs [9]. 
 
The high resistance of Enterobacter 
organisms is associated with the production 
of extended spectrum β-lactamase which 
confers on them resistance to many 
antibiotics. β-Lactamases are the major 
defense systems of Gram-negative bacteria 
[16]. Since β-lactam antibiotics came into 
clinical use, β-lactamase evolved with them 
[17]. It is very likely that Enterobacter species 
acquired their resistance to drugs through the 
production of this enzyme, β-lactamase. 
Worst still, enterobacter species together with 
some members of Enterobacteriaceae carry 
a gene for chromosomally encoded β-
lactamase. Unlike the plasmid-mediated 
gene, the enzyme is not usually expressed in 
the uninducible form. They become induced 
by antibiotics, body fluids and some amino 
acids. It is a concern that organisms such as 
Enterobacter aerogenes harboring genes for 
inducible β-lactamase may show false 
susceptibility if tested in the uninduced 
state[16]. This may explain the causes of 
some treatment failures as the organism 
develops resistance during therapy. For this 
reason, management of any enterobacter 
infection should be done with caution. 
 
Risk factors for enterobacter infections 
include not only long hospitalization and 
presence of indwelling catheters since 
infections have also been traced to 
equipment, contaminated objects and hands 
of hospital personnel. The risk factors for 
extended spectrum beta lactamase (ESBL)-
producing organisms are little different from 
the risk factors of other nosocomial infections 
[18]. In outbreak situations, successful 
intervention has usually involved the 
institution of barrier precautions in the form of 
hand washing, as well wearing of cloves and 
gowns. Presently, there are no β-lactam 
antibiotics in development that can treat 
infections caused by organisms producing 
some of the new β-lactamases. The available 
agents should be used judiciously and 
effective control measures should be 
implemented in situations of outbreak to 




The frequency of isolation of Enterobacter 
species from clinical specimens obtained 
from University of Benin Teaching Hospital, 
Nigeria was low. Virulence and remarkable 
drug resistance of the organisms make them 
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